Related Experiment Video
Updated: Sep 11, 2025

Improved Home Blood Pressure Control by CT-guided Ozone-mediated Renal Denervation for Patients with Resistant Hypertension
Published on: June 6, 2025
A scoping review of neuromodulation techniques for controlling blood pressure: what are the ups and downs to this
Peter L Greechan1, Ryan G L Koh1,2, Paul B Yoo3,4
1Institute of Biomedical Engineering, University of Toronto, Toronto, ON, M5S 3E2, Canada.
Background And Objectives:
While there has been rapid progress in research aimed at developing device-based neuromodulation therapies for blood pressure (BP) disorders, there is a paucity of FDA-approved therapies. Currently, the only approved devices for treating resistant hypertension use renal denervation, however, this could soon change as clinical research progresses. With the evolution of interventional strategies for BP regulation, it is important to comprehend the developments to date in order to gauge directions for future research. The objective of this scoping review was to provide the current range of device-based BP neuromodulation approaches, overview salient characteristics of the included studies, address limitations, and detail avenues of further investigation.
Methods:
Our review was conducted using the Preferred Reporting Items for Reviews and and Meta-analysis framework. The literature search was performed across the Web of Science Core Collection, Scopus, and Pubmed databases. The search yielded 3503 studies, of which 100 studies remained following the screening process. In the last 10 years, there has been an increase in the number of experimental neurostimulation studies detailing increases and decreases in BP. Of all the included studies, most adopted a non-randomized experimental approach (89%), used animal participants (65%), used invasive neuromodulation methods (74%), and performed acute experiments (84%). More studies documented only depressor responses (49%) compared to pressor responses (35%), and 13% reported both pressor and depressor responses using multiple neural targets.
Conclusions:
This review addressed developments in device-based BP neuromodulation, highlighting a dominant focus on treating resistant hypertension compared to hypotensive disorders. While advancements in implantable electrodes have improved spatial selectivity of stimulation, non-invasive neurostimulation devices have become increasingly popular in recent years.
Related Concept Videos
Neural Regulation of Blood Pressure
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension and Regulation of Blood Pressure
Blood Pressure
The average BP in an adult is typically around 120/80 mmHg (millimeters of mercury). In this measurement, the numerator (120) indicates the systolic pressure, which is the pressure in the arteries during the contraction of the heart's ventricles as blood is expelled. The denominator (80) represents the...
Pre-Procedural Guidelines for Assessing Blood Pressure
Hormonal Regulation of Blood Pressure
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...

